The South Korean government passed the Bioethics and Biosafety Act, referred to from this time forward as the Bioethics Act, in 2003 and it produced results in 2005. South Korea's Ministry of Health and Welfare proposed the law toward the South Korean National Assembly to permit the advancement of biotechnology and life sciences scrutinize in South Korea while ensuring human exploration subjects with practices, for example, educated assent. The Bioethics Act builds up a National Bioethics Committee in Seoul, South Korea. The Bioethics Act is the first law in South Korea to control investigates on embryonic foundational microorganisms and in vitro preparation. Most South Korean bioethical strategies depend on this demonstration and its procurements.